Lactobacillus plantarum LP01 and Improved Gastrointestinal Symptoms

• Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.

  • 2019-07-10
  • Clinical Trial
  • Acta bio-medica : Atenei Parmensis 90(7-S)
  • • Luigi Bonavina
    • Andrea Arini
    • Leonardo Ficano
    • Donato Iannuzziello
    • Luigi Pasquale
    • Salvo Emanuele Aragona
    • Giorgio Ciprandi
    • Italian Study Group On Digestive Disorders

  • PubMed: 31292420
  • DOI: 10.23750/abm.v90i7-s.8649

  2 Insights on

  • Improved Gastrointestinal Symptoms

  • Moderate evidence

  Abincol® significantly diminished the presence and the severity of intestinal symptoms and improved stool form.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes